Phillip Johnson

Phillip Johnson is an accomplished finance executive with extensive experience in chief financial officer roles across multiple organizations, including QbDVision, Orbis Health Solutions, and Elios Holdings since 2019. Johnson's expertise encompasses consulting, fundraising, and scaling CFO services, particularly for companies with disruptive technology platforms. Significant achievements include driving the valuation of Xeris Pharmaceuticals from $20 million to $121 million and contributing to market capitalization increases at ArthroCare Corporation and Maverick Tube Corporation. Johnson's professional background also includes leadership roles at Services Company and KPMG, where financial strategies and internal controls were effectively implemented. Johnson earned a BA in Accounting from Furman University.